Keurig Dr Pepper Inc. — Q2 2020 Form 10-Q
Business context and period: The filing covers the quarter and six months ended June 30, 2020. KDP operates four segments: Coffee Systems, Packaged Beverages, Beverage Concentrates, and Latin America Beverages. Results were materially shaped by COVID-19-related shifts between at-home and away-from-home demand.
Financial performance
- Second quarter: Net sales were $2.864 billion, up 1.8% year over year. Net income was $298 million, down 5.1%; diluted EPS was $0.21, down 4.5%. Gross profit fell 3.9% to $1.562 billion. Gross margin declined 330 basis points to 54.5%, and operating margin fell 130 basis points to 19.6%.
- First six months: Net sales were $5.477 billion, up 3.0%. Net income declined 16.5% to $454 million; diluted EPS was $0.32 versus $0.38. Gross margin decreased 190 basis points to 55.0%, and operating margin fell 160 basis points to 18.8%. The decline in net income primarily reflected an $86 million noncash impairment of the Bedford investment and related note receivable.
- Adjusted results (non-GAAP): Q2 adjusted net income rose 10.9% to $469 million and adjusted diluted EPS rose 10.0% to $0.33; adjusted operating margin expanded 210 basis points to 27.1%. For six months, adjusted net income increased 11.7% to $877 million and adjusted diluted EPS increased 12.7% to $0.62. These measures exclude specified items; see the filing’s reconciliations.
- Segment trends, Q2: Coffee Systems sales rose 5.4%, with K-Cup pod volume up 9.5% and brewer volume up 11.6%. Packaged Beverages sales increased 6.2%. Beverage Concentrates sales fell 16.5%, including a 10.5% volume decline as fountain and foodservice demand weakened. Latin America Beverages sales fell 14.9%, mainly due to unfavorable foreign exchange.
- Cash flow: Six-month operating cash flow was $1.062 billion, versus $1.203 billion in 2019. Investing activities used $92 million and financing activities used $901 million. Capital expenditures were $276 million; asset-sale proceeds were $202 million. Dividends paid were $423 million.
- Debt and liquidity: At June 30, total short- and long-term obligations were $14.105 billion, versus $14.420 billion at year-end 2019. Cash and cash equivalents were $149 million, plus $28 million of restricted cash. Current liabilities exceeded current assets by about $5.1 billion. KDP issued $1.5 billion of 2030 and 2050 notes in April, used proceeds to repay revolver borrowings, and increased its 364-day credit facility to $1.5 billion. The company reported $3.9 billion of availability under committed facilities as of July 30 and compliance with debt covenants at June 30.
Material changes and management commentary
- COVID-19 boosted at-home coffee and packaged beverage demand, while office, hospitality, convenience/gas, and fountain foodservice channels weakened. Management cited strong demand-related logistics and labor costs, lower marketing spending, and cost discipline.
- Q2 reported results included $75 million of identified COVID-19-related costs. For the first six months, identified costs were $90 million, including employee compensation, employee protection, expected credit-loss allowances, and inventory write-downs.
- Management attributed Q2 adjusted earnings growth to volume/mix, productivity, merger synergies, and reduced marketing, partly offset by lower pricing and increased operating costs. Six-month adjusted performance also benefited from a $42 million network-optimization gain on asset sale-leasebacks.
- KDP continued its DPS integration program, targeting $600 million of synergies over three years. It expected total program cash expenditures of $750 million and reported approximately $492 million of cumulative pretax charges through June 30, 2020.
- Management said liquidity remained strong and operating cash flows should meet anticipated obligations over the next 12 months. It noted uncertainty around pandemic-driven demand, supply-chain continuity, customer credit, and economic recovery.
Guidance, risks, and contingencies
- Management maintained full-year 2020 guidance for constant-currency net sales growth of 3%–4% and adjusted diluted EPS growth of 13%–15%, or $1.38–$1.40 per share. It expected a year-end management leverage ratio of 3.5x–3.8x and a ratio below 3.0x within two to three years of the July 2018 merger closing.
- COVID-19 could drive demand volatility, reduced away-from-home sales, supply or workforce disruptions, higher costs, and customer or supplier financial stress. The company cautioned that impacts and recovery timing were difficult to predict.
- In July 2020, KGM agreed to a $31 million settlement with putative indirect purchasers in single-serve coffee antitrust litigation; court approval and class-member procedures remained pending. Other antitrust claims, including direct-purchaser and Canadian litigation, remained unresolved, and potential losses could not be estimated.
- The company also disclosed unresolved Proposition 65 coffee-warning litigation, with potential penalties or labeling requirements that could affect costs and sales. In separate BodyArmor litigation, Coca-Cola was added as a defendant in June 2020; outcome and potential recovery were uncertain.
- Bedford’s revised outlook led to a full impairment of its $55 million note receivable and a $31 million impairment of the investment. KDP stopped recognizing its share of Bedford losses after the investment’s carrying value reached zero.
Key facts for investors to verify
- Whether reported demand growth—particularly at-home coffee and Packaged Beverages—persists as pandemic conditions and consumer behavior change.
- Whether away-from-home and fountain volumes recover, and the effect of pricing, foreign exchange, input costs, and COVID-related expenses on margins.
- Progress against 2020 sales, adjusted EPS, leverage, and merger-synergy targets; assess adjusted measures alongside GAAP results and exclusions.
- Debt maturities, facility availability, refinancing costs, supplier-payment arrangements, and the sustainability of cash generation and dividends.
- Developments in the antitrust, Proposition 65, and BodyArmor matters, including settlement approval and any future loss estimates.